NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.520
-0.060 (-2.33%)
At close: Aug 28, 2025, 4:00 PM
2.530
+0.010 (0.40%)
After-hours: Aug 28, 2025, 7:53 PM EDT

NRx Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Selling, General & Admin
10.713.5114.2227.3174.9411.44
Upgrade
Research & Development
3.446.213.3717.0320.2610.63
Upgrade
Other Operating Expenses
-----0.77-10.16
Upgrade
Operating Expenses
14.1319.727.5944.3494.4311.9
Upgrade
Operating Income
-14.13-19.7-27.59-44.34-94.43-11.9
Upgrade
Interest Expense
--0.23-0.12--0.02-0.06
Upgrade
Interest & Investment Income
0.020.040.490.25--
Upgrade
Other Non Operating Income (Expenses)
-11.94-3.780.020.261.69-0.03
Upgrade
EBT Excluding Unusual Items
-26.05-23.67-27.19-43.83-92.76-11.98
Upgrade
Other Unusual Items
-7.74-1.45-2.964.08-0.31-39.79
Upgrade
Pretax Income
-33.79-25.13-30.15-39.75-93.06-51.78
Upgrade
Net Income
-33.79-25.13-30.15-39.75-93.06-51.78
Upgrade
Preferred Dividends & Other Adjustments
--0.01---
Upgrade
Net Income to Common
-33.79-25.13-30.16-39.75-93.06-51.78
Upgrade
Shares Outstanding (Basic)
14118753
Upgrade
Shares Outstanding (Diluted)
14118753
Upgrade
Shares Change (YoY)
61.59%40.50%15.20%40.17%36.90%220.58%
Upgrade
EPS (Basic)
-2.35-2.36-3.98-6.04-19.84-15.11
Upgrade
EPS (Diluted)
-2.35-2.36-3.98-6.04-74.40-15.11
Upgrade
Free Cash Flow
-11.91-10.64-21.66-39.77-37.71-2.27
Upgrade
Free Cash Flow Per Share
-0.83-1.00-2.86-6.05-8.04-0.66
Upgrade
EBITDA
-14.13-19.7-27.58-44.33-94.43-11.9
Upgrade
D&A For EBITDA
0.010.010.01000
Upgrade
EBIT
-14.13-19.7-27.59-44.34-94.43-11.9
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q